AbbVie Cash Conversion Cycle | ABBV

Annual Cash Conversion Cycle AbbVie

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
284	89.3	84.7	76.1	74.4	73.3	77.3	62.8	72.6	70.1	85.4	98.5	111	129	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
284	62.8	99.1

Quarterly Cash Conversion Cycle AbbVie

2026-Q2	2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	159	174	184	167	167	178	132	160	170	-	61.9	71.7	112	59	128	131	111	58.1	122	159	162	56.9	145	151	113	59.2	139	135	101	60	157	66.9	68.7	65.5	69.2	67.3	72.7	66.3	71.4	78.8	76.6	62.5	67.9	69.2	75.9	68.8	75.5	75	85.9	75.3	87	87.3	47	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
184	47	103

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Aclaris Therapeutics ACRS	-1.55 K	$ 5.32	0.09 %	$ 652 M	USA
ADC Therapeutics SA ADCT	-543	$ 1.05	0.46 %	$ 133 M	Schweiz
Agenus AGEN	-25.8 K	$ 7.21	0.7 %	$ 214 M	USA
Фармсинтез LIFE	-15.9	-	-	-	Russia
Akebia Therapeutics AKBA	42	$ 0.92	1.64 %	$ 237 M	USA
Alector ALEC	-13.8	$ 1.93	0.81 %	$ 199 M	USA
Alkermes plc ALKS	299	$ 46.07	0.09 %	$ 7.59 B	Irlanda
Alnylam Pharmaceuticals ALNY	31.7	$ 239.36	0.46 %	$ 31.4 B	USA
Altimmune ALT	7.85 K	$ 3.24	0.31 %	$ 285 M	USA
Amphastar Pharmaceuticals AMPH	205	$ 23.95	1.31 %	$ 1.12 B	USA
AnaptysBio ANAB	58	$ 54.31	0.15 %	$ 1.56 B	USA
Anika Therapeutics ANIK	192	$ 20.84	0.24 %	$ 299 M	USA
ANI Pharmaceuticals ANIP	196	$ 73.59	2.05 %	$ 1.48 B	USA
Aptevo Therapeutics APVO	-47.4	$ 1.72	0.58 %	$ 543 K	USA
Aquestive Therapeutics AQST	-172	$ 4.82	0.21 %	$ 515 M	USA
Arcturus Therapeutics Holdings ARCT	21.2	$ 15.6	0.25 %	$ 427 M	Israel
Assembly Biosciences ASMB	2.46	$ 25.48	0.54 %	$ 286 M	USA
Atara Biotherapeutics ATRA	4.13	$ 10.11	7.1 %	$ 127 M	USA
Aurinia Pharmaceuticals AUPH	612	$ 16.96	5.15 %	$ 2.28 B	Canada
Autolus Therapeutics plc AUTL	119	$ 1.87	0.53 %	$ 498 M	Britain
Axon Enterprise AXON	64.5	$ 468.42	5.96 %	$ 36.6 B	USA
Axsome Therapeutics AXSM	-256	$ 211.97	3.87 %	$ 10.5 B	USA
Aytu BioScience AYTU	174	$ 1.97	0.5 %	$ 12.4 M	USA
BridgeBio Pharma BBIO	-114	$ 68.3	0.1 %	$ 13.1 B	USA
Bicycle Therapeutics plc BCYC	13.8	$ 3.64	0.68 %	$ 252 M	Britain
Biogen BIIB	337	$ 216.01	0.42 %	$ 31.6 B	USA
AbCellera Biologics ABCL	173	$ 11.67	2.28 %	$ 3.49 B	Canada
Benitec Biopharma BNTC	141	$ 11.04	0.9 %	$ 514 M	USA
Clovis Oncology CLVS	271	-	-7.23 %	$ 13 M	USA
Chimerix CMRX	52.5	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	5.06	-	-	$ 401 M	USA
Catalyst Biosciences CBIO	285	$ 17.18	1.7 %	$ 1.53 B	USA
C4 Therapeutics CCCC	27.9	$ 3.45	0.58 %	$ 286 M	USA